Maarten J. Postma
Impact in
- Microbiology top 0.2%
- Reproductive tract infections research
- Family Practice top 0.5%
Papers in
- Epidemiology 181
- Influenza Virus Research Studies 65
- Pneumonia and Respiratory Infections 39
- Cervical Cancer and HPV Research 29
- Respiratory viral infections research 29
-
- Health Systems, Economic Evaluations, Quality of Life 112
- Pharmaceutical Economics and Policy 42
- Co-authors
- Mark H. Rozenbaum (36 shared papers)Stefan Vegter (26 shared papers)Job F. M. van Boven (44 shared papers)Cornelis Boersma (60 shared papers)Eelko Hak (27 shared papers)Mirjam Kretzschmar (9 shared papers)Marinus van Hulst (45 shared papers)Jan Wilschut (40 shared papers)
- Journals
- Value in Health (123 papers)PLoS ONE (44 papers)Vaccine (44 papers)PharmacoEconomics (38 papers)Expert Review of Vaccines (21 papers)
- Partner nations
- NetherlandsIndonesiaUnited Kingdom
In The Last Decade
Maarten J. Postma
740 papers receiving 12.5k citations
Maarten J. Postma's Hit Papers
Peers
Comparison fields: 5 of 196
- Microbiology 893
- Family Practice 206
- Health 831
- Applied Microbiology and Biotechnology 195
- Epidemiology 3.0k
Countries citing papers authored by Maarten J. Postma
This map shows the geographic impact of Maarten J. Postma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten J. Postma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten J. Postma more than expected).
Fields of papers citing papers by Maarten J. Postma
This network shows the impact of papers produced by Maarten J. Postma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten J. Postma. The network helps show where Maarten J. Postma may publish in the future.
Co-authors
The 25 scholars most cited alongside Maarten J. Postma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 791 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI Hit paper breakdown → | 2019 | 390 |
| 2 | 1997 | 310 | |
| 3 | Reducing the costs of chronic kidney disease while delivering quality health care: a call to action Hit paper breakdown → | 2017 | 230 |
| 4 | Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy Hit paper breakdown → | 2020 | 228 |
| 5 | 2011 | 216 | |
| 6 | 2013 | 169 | |
| 7 | 2005 | 158 | |
| 8 | 2012 | 156 | |
| 9 | 2009 | 152 | |
| 10 | 2008 | 109 | |
| 11 | 2012 | 108 | |
| 12 | 2013 | 106 | |
| 13 | 1999 | 106 | |
| 14 | 2010 | 103 | |
| 15 | 2013 | 98 | |
| 16 | 2001 | 97 | |
| 17 | 2017 | 97 | |
| 18 | 2015 | 95 | |
| 19 | 2018 | 91 | |
| 20 | 2011 | 91 |
About Maarten J. Postma
Maarten J. Postma is a scholar working on Epidemiology, Economics and Econometrics, Infectious Diseases, Health and General Health Professions, having authored 791 papers that have together received 12.9k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (112 papers), Vaccine Coverage and Hesitancy (67 papers), Influenza Virus Research Studies (65 papers), Pharmaceutical Economics and Policy (42 papers), Pneumonia and Respiratory Infections (39 papers), Viral gastroenteritis research and epidemiology (32 papers), Cervical Cancer and HPV Research (29 papers) and Respiratory viral infections research (29 papers). The work is most often cited by research in Microbiology (893 citations), Family Practice (206 citations), Health (831 citations), Applied Microbiology and Biotechnology (195 citations) and Epidemiology (3.0k citations). Maarten J. Postma has collaborated with scholars based in Netherlands, Indonesia and United Kingdom. Frequent co-authors include Mark H. Rozenbaum, Stefan Vegter, Job F. M. van Boven, Cornelis Boersma, Eelko Hak, Mirjam Kretzschmar, Marinus van Hulst, Jan Wilschut, R Welte and J. C. Jager. Their work appears in journals such as Value in Health, PLoS ONE, Vaccine, PharmacoEconomics and Expert Review of Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.